Search
Filter by content type
Filter by content year
Filter by category
BioNTech Announces Plans for a Clinical Trial hub in Taiwan for mRNA-based Cancer Immunotherapies as Part of Asia-Pacific Expansion
December 16, 2022 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech und Pfizer geben Genehmigung des Paul-Ehrlich-Instituts für erste klinische Studie von COVID-19-Impfstoffkandidaten bekannt
April 22, 2020 - … sicherstellen. Zudem arbeitet BioNTech gemeinsam mit Fosun Pharma an der Entwicklung von BNT162 innerhalb Chinas, … Genentech (ein Unternehmen der Roche Gruppe), Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … zwischen BioNTech und Pfizer sowie BioNTech und Fosun Pharma zur Entwicklung eines potenziellen Impfstoffs …
Pfizer und BioNTech impfen erste US-Studienteilnehmer im Rahmen des globalen Programms zur COVID-19-mRNA-Impfstoffentwicklung
May 5, 2020 - … (China ausgenommen, wo BioNTech eine Zusammenarbeit mit Fosun Pharma für die klinische Entwicklung sowie die … Genentech (ein Unternehmen der Roche Gruppe), Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … zwischen BioNTech und Pfizer sowie BioNTech und Fosun Pharma zur Entwicklung eines potenziellen Impfstoffs …
Pfizer and BioNTech Announce New England Journal of Medicine Publication of Phase 1 Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19
October 14, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
June 2, 2023 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit …
Pfizer und BioNTech veröffentlichen erste positive Daten aus laufender deutscher Phase-1/2-COVID-19-Impfstoffstudie samt vorläufigen Ergebnissen zur T-Zell-Antwort
July 20, 2020 - … (ausgenommen China, wo BioNTech eine Partnerschaft mit Fosun Pharma für die klinische Entwicklung und … Genentech (ein Unternehmen der Roche Gruppe), Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … zwischen BioNTech und Pfizer sowie BioNTech und Fosun Pharma zur Entwicklung eines potenziellen Impfstoffs …
BioNTech and Pfizer Receive Regulatory Approval From Paul-Ehrlich-Institut to Commence German Part of Global Phase 2/3 Trial for COVID-19 Vaccine Candidate BNT162b2
September 7, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
Positive Phase 1 Data from mRNA-based Individualized Neoantigen Specific Immunotherapy in Patients with Resected Pancreatic Cancer presented at ASCO
June 5, 2022 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit …
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC
June 29, 2023 - … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
October 6, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …